Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: Characterisation of its reactive antigen via immunoprecipitation and internal sequencing

Journal of Immunological Methods

Volumn 303, Issue 1-2, 2005, Pages 53-65

  Larkin, Annemarie ^a   Moran, Elizabeth ^a   Kennedy, Susan M ^b   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

Formalin fixed paraffin embedded tissue; Immunohistochemistry; Immunoprecipitation; Invasive breast carcinoma; Monoclonal antibody; Novel antigen

Indexed keywords

CYTOKERATIN; CYTOKERATIN 6; CYTOKERATIN 9; FORMALDEHYDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5C3; PARAFFIN; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY ISOLATION; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RELAPSE; CELL INFILTRATION; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HL-60 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; NEOPLASM INVASIVENESS; SPLEEN; TISSUE FIXATION;

MURINAE;

EID: 23844475202     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.05.011     Document Type: Article

References (26)

1. D.M. Abd El-Rehim, S.E. Pinder, C.E. Paish, J. Bell, R.W. Blamey, J.F.R. Robertson, R.I. Nicholson, and I.O. Ellis Expression of luminal and basal cytokeratins in human breast carcinoma J. Pathol. 203 2004 661
2. L. Bjorck Protein L A novel bacterial cell wall protein with affinity for IgL chains J. Immunol. 140 1988 1194
3. A. Bradbury, N. Velappan, V. Verzillo, M. Ovecka, L. Chasteen, D. Sblattero, R. Marzari, J. Lou, lR. Siege, and P. Pavlik Antibodies in proteomics II: screening, high-throughput characterization and downstream applications Trends Biotechnol. 21 2003 27
4. A. Bradbury, N. Velappan, V. Verzillo, M. Ovecka, L. Chasteen, D. Sblattero, R. Marzari, J. Lou, R. Siegel, and P. Pavlik Antibodies in proteomics I: generating antibodies Trends Biotechnol. 21 2003 275
5. M. Clynes, A. Redmond, E. Moran, and U. Gilvarry Multiple drug resistance in variants of a human non-small cell, DLKPA Cytotechnology 10 1992 75
6. L.W. Engel, N.A. Young, T.S. Tralka, M.E. Lippman, S.J. O'Brien, and M.J. Joyce Establishment and characterisation of three new continuous cell lines derived from human breast carcinomas Cancer Res. 38 1978 3352
7. S.M. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase techniques J. Histochem. 29 1981 577
8. E.D. Jarasch, R.B. Nagle, M. Kaufmann, C. Maurer, and W. Bocker Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins Human Pathol. 19 1988 276
9. G. Kohler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature (Lond.) 256 1975 495
10. E. Korsching, J. Packeisen, K. Agelopoulos, M. Eisenacher, R. Voss, J. Isola, P.J. van Diest, B. Brandt, W. Boecker, and H. Buerger Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis Lab. Invest. 82 2002 1525
11. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature (Lond.) 227 1970 680
12. Larkin, A., 2002. The Expression of Multiple Drug Resistance proteins in invasive breast cancer. PhD thesis, Dublin City University.
13. A. Larkin, L. O'Driscoll, S. Kennedy, R. Purcell, E. Moran, J. Crown, M. Parkinson, and M. Clynes Investigation of MRP-1 protein and MDR-1 Pgp expression in invasive breast cancer: a prognostic study Int. J. Cancer 112 2004 286
14. E. Law, U. Gilvarry, V. Lynch, B. Gregory, G. Grant, and M. Clynes Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines Cancer Genet. Cytogenet. 59 1992 111
15. Y. Liang, P. Meleady, I. Cleary, S. McDonnell, L. Connolly, and M. Clynes Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness Eur. J. Cancer 37 2001 1041
16. R. Moll, W. Franke, and Schiller The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells Cell 31 1982 11
17. E. Moran, I. Cleary, A.M. Larkin, R.N. Amhlaoibh, A. Masterson, R.J. Scheper, M.A. Izquierdo, M. Center, F. O'Sullivan, and M. Clynes Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42 Eur. J. Cancer 33 1997 652
18. E. Moran, A. Larkin, I. Cleary, C. Barnes, S.M. Kennedy, P. Kelehan, and M. Clynes Monoclonal antibodies raised to paraffin-wax embedded archival tissue; feasibility study of their potential to detect novel antigenic markers J. Immunol. Methods 219 1998 151
19. F. Otterbach, A. Bankfalvi, S. Bergner, T. Decker, R. Krech, and W. Boecker Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast Histopathology 37 2000 232
20. G.F. Pancino, E. Osinaga, W. Voraucher, A. Kakouche, D. Mistro, C. Charpin, and A. Roseto Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunisation method Hybridoma 9 1990 389
21. D. Porter, S. Weremowicz, K. Chin, P. Seth, A. Keshaviah, J. Lahti-Domenici, Y.K. Bae, C.L. Monitto, A. Merlos-Suarez, J. Chan, C.M. Hulette, A. Richardson, C.C. Morton, J. Marks, M. Duyao, R. Hruban, E. Gabrielson, R. Gelman, and K. Polyak A neural survival factor is a candidate oncogene in breast cancer Proc. Natl. Acad. Sci. U. S. A. 100 2003 10931
22. E. Ronchi, O. Sanfilippo, G. Di Fronzo, M.R. Bani, G. Della Torre, S. Catania, and R. Silvestrini Detection of the 170 kDa P-glycoprotein in neoplastic and normal tissues Tumori 75 1989 542
23. M. Schachner, K.A. Worthman, Rubergniz, S. Dorfman, and G.L.M. Campbell Brain surface antigens detected by anti-corpus callosum antiserum Brain Res. 127 1977 87
24. D.D. Sloan, B. Nicholson, V. Urquidi, and S. Goodison Detection of differentially expressed genes in an isogenic breast metastasis model using RNA arbitrarily primed-polymerase chain reaction coupled with array hybridization (RAP-array) Am. J. Pathol. 164 2004 315
25. S.A. Stacker, C. Thompson, C. Riglar, and I.F. McKenzie A new breast carcinoma antigen defined by a monoclonal antibody J. Natl. Cancer Inst. 75 1985 801
26. H. Towbin, T. Stashelin, and J. Gordan Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications Proc. Natl. Acad. Sci. U. S. A. 76 1979 4350